Spreading of Xist RNA and Polycomb complexes along the inactive X-chromosome.
Xist RNA 和 Polycomb 复合物沿着非活性 X 染色体扩散。
基本信息
- 批准号:10001559
- 负责人:
- 金额:$ 70.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-01 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalATRX geneAchievementAddressArchitectureAwardBase SequenceBindingBinding SitesBiochemicalBiochemistryBiologyCatalytic DomainCellular biologyChromatinChromosomesComplexDevelopmentDosage Compensation (Genetics)EZH2 geneEpigenetic ProcessFundingGene ExpressionGenesGeneticGenomicsGoalsHistonesIn VitroLinkLiteratureMaintenanceMammalsMapsMethodsModelingMolecular ChaperonesMutagenesisNatureNucleic AcidsPolycombProcessProteinsPublishingRNARNA-Protein InteractionReactionRecurrenceRegulationResearchResolutionRoleShort Interspersed Nucleotide ElementsSiteSpecificityStressStructureSystems BiologyTranscriptUnited States National Institutes of HealthUntranslated RNAWorkX ChromosomeX Inactivationbasebiological adaptation to stresscohesindeletion analysisepigenetic regulationepigenomicsfollow-upfrontiergenome-widehistone methyltransferaseimplantationin vivomammalian genomemolecular imagingnatural Blastocyst Implantationnucleaseprogramsprototyperesponsesingle molecule
项目摘要
PROJECT SUMMARY
Our research program is unified by an effort to understand the mechanisms underlying X-chromosome
inactivation (XCI) and how functional interactions between Polycomb repressive complex 2 (PRC2) and long
noncoding RNA (lncRNA) spread the silencing process through the X-chromosome. XCI is the dosage
compensation process in mammals that leads to silencing of one X-chromosome in the peri-implantation
embryo. The X-inactivation center (Xic) — the X-linked region that controls the initiation, spread, and
maintenance of silencing — harbors a large number of genes encoding functional lncRNAs, including the
prototype, Xist, a 17-kb RNA that “coats” the inactive X (Xi) to initiate silencing. Towards understanding
mechanisms, in 2008 we identified Polycomb repressive complex 2 (PRC2) as an interacting protein partner
for Xist RNA. PRC2 is the epigenetic complex responsible for trimethylating H3 lysine27 (H3K27me3). Under
this NIH award, we have identified of a “nucleation center” required for loading of Xist-Polycomb complexes
onto the Xi prior to spreading, defined YY1 as the tether, and demonstrated that Xist RNA is but one of
thousands of RNA partners for EZH2, the catalytic subunit of PRC2. We have hypothesized that regulatory
interactions between PRC2 and RNA would become a recurrent theme in epigenetic regulation. Two major
unsolved problems in the field are how the interaction specificity between PRC2 and RNA is achieved and how
they regulate gene expression in a locus-specific manner. In the past funding cycle, we have made significant
progress towards addressing these problems. We have: (i) mapped Xi-binding sites for Xist RNA and PRC2,
(ii) performed single-molecule imaging of the Xist-PRC2 relationship on the Xi, (iii) defined the interaction
specificity and regulatory interactions between Xist's Repeat A motif and various subunits of PRC2, (iv)
identified an in vivo chaperone that helps determine the interaction specificity between Xist and PRC2, and (v)
revealed a role for SMCHD1 (a chromosome architectural protein) in the regional spreading of Xist-PRC2
complexes. We have furthermore discovered a surprising non-canonical activity of EZH2 — an activity
independent of its histone methyltransferase activity and that triggers a site-specific cleavage of a SINE repeat
RNA (B2) during the stress response. In the next five years, we will address key follow-up questions. First, we
aim to define specific motifs for the Polycomb-RNA interaction and understand how ATRX influences the
interaction. Second, we will investigate underlying mechanisms for the Xist-PRC2 "spreading" function on the
Xi through mutagenesis of Xist and perturbation of factors required for higher order Xi structures. Finally, we
will examine how EZH2 triggers site-specific cleavage of RNA and determine whether this activity impacts XCI.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JEANNIE T LEE其他文献
JEANNIE T LEE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JEANNIE T LEE', 18)}}的其他基金
Investigating a candidate therapeutic for Rett Syndrome
研究雷特综合征的候选疗法
- 批准号:
10612000 - 财政年份:2019
- 资助金额:
$ 70.44万 - 项目类别:
Spreading of Xist RNA and Polycomb complexes along the inactive X-chromosome.
Xist RNA 和 Polycomb 复合物沿着非活性 X 染色体扩散。
- 批准号:
10178063 - 财政年份:2019
- 资助金额:
$ 70.44万 - 项目类别:
Investigating a candidate therapeutic for Rett Syndrome
研究雷特综合征的候选疗法
- 批准号:
10405454 - 财政年份:2019
- 资助金额:
$ 70.44万 - 项目类别:
Investigating a candidate therapeutic for Rett Syndrome
研究雷特综合征的候选疗法
- 批准号:
9814949 - 财政年份:2019
- 资助金额:
$ 70.44万 - 项目类别:
Spreading of Xist RNA and Polycomb complexes along the inactive X-chromosome.
Xist RNA 和 Polycomb 复合物沿着非活性 X 染色体扩散。
- 批准号:
9816527 - 财政年份:2019
- 资助金额:
$ 70.44万 - 项目类别:
Spreading of Xist RNA and Polycomb complexes along the inactive X-chromosome.
Xist RNA 和 Polycomb 复合物沿着非活性 X 染色体扩散。
- 批准号:
10428516 - 财政年份:2019
- 资助金额:
$ 70.44万 - 项目类别:
Spreading of Xist RNA and Polycomb complexes along the inactive X-chromosome.
Xist RNA 和 Polycomb 复合物沿着非活性 X 染色体扩散。
- 批准号:
10626024 - 财政年份:2019
- 资助金额:
$ 70.44万 - 项目类别:
The RNA-activation platform to treat X-linked disease in a locus-specific manner.
RNA 激活平台以位点特异性方式治疗 X 连锁疾病。
- 批准号:
8737219 - 财政年份:2013
- 资助金额:
$ 70.44万 - 项目类别:
The RNA-activation platform to treat X-linked disease in a locus-specific manner.
RNA 激活平台以位点特异性方式治疗 X 连锁疾病。
- 批准号:
8642462 - 财政年份:2013
- 资助金额:
$ 70.44万 - 项目类别:
The RNA-activation platform to treat X-linked disease in a locus-specific manner.
RNA 激活平台以位点特异性方式治疗 X 连锁疾病。
- 批准号:
9318484 - 财政年份:2013
- 资助金额:
$ 70.44万 - 项目类别:
相似海外基金
Molecular pathological mechanisms of the brain development disorder using the chromatin-remodeling molecule ATRX gene knockout mouse
染色质重塑分子ATRX基因敲除小鼠脑发育障碍的分子病理机制
- 批准号:
23300147 - 财政年份:2011
- 资助金额:
$ 70.44万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Functional analysis of the Zn finger domain encoded by the ATRX gene whose mutations result in X-linked alpha thalassemia mental retardation(ATR-X) syndrome
ATRX基因编码的锌指结构域的功能分析,其突变导致X连锁α地中海贫血精神发育迟滞(ATR-X)综合征
- 批准号:
18570170 - 财政年份:2006
- 资助金额:
$ 70.44万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A Y CHROMOSOME MODEL FOR THE SEX DETERMINING FUNCTION OF THE HUMAN ATRX GENE
人类 ATRX 基因性别决定功能的 Y 染色体模型
- 批准号:
nhmrc : 148630 - 财政年份:2001
- 资助金额:
$ 70.44万 - 项目类别:
NHMRC Project Grants
Investigation of the role of the ATRX gene in normal mammalian development
ATRX 基因在正常哺乳动物发育中的作用研究
- 批准号:
nhmrc : 987013 - 财政年份:1998
- 资助金额:
$ 70.44万 - 项目类别:
Early Career Fellowships